[go: up one dir, main page]

Hu, 2021 - Google Patents

The immunoregulation of autoimmune diabetes

Hu, 2021

View PDF
Document ID
4026509138612333635
Author
Hu H
Publication year

External Links

Snippet

How autoimmune diseases are regulated is a long-term research topic in the autoimmunity field. We use autoimmune diabetes as a model to study this. Autoimmune diabetes is a T cell- dependent autoimmune syndrome. The functions of T cells are regulated during their …
Continue reading at openscholarship.wustl.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Similar Documents

Publication Publication Date Title
JP7123794B2 (en) Immune cell compositions and methods of using same
Bour‐Jordan et al. Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/B7 family
Roep et al. Immune modulation in humans: implications for type 1 diabetes mellitus
EP3469362B1 (en) Human leukocyte antigen restricted gamma delta t cell receptors and methods of use thereof
US9018006B2 (en) Stable Tregs and related materials and methods
JP7594439B2 (en) Major histocompatibility complex-based chimeric receptors and their use for treating autoimmune diseases - Patents.com
US20250352582A1 (en) Compositions and methods for targeting cd13 and tim-3 with car t cells to treat acute myeloid leukemia
Han et al. Effective anti-tumor response by TIGIT blockade associated with FcγR engagement and myeloid cell activation
Redondo-García et al. Human leukocyte immunoglobulin-like receptors in health and disease
Obarorakpor et al. Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes
US20220381772A1 (en) Systems and methods for evaluating nk cells
Danese et al. The Janus face of CD4+ CD25+ regulatory T cells in cancer and autoimmunity
Lonberg The Problem with Syngeneic Mouse Tumor Models
Matsuda et al. Approaches for controlling antibody-mediated allograft rejection through targeting B cells
US20110044939A1 (en) Regulatory t cells in adipose tissue
Chen et al. Essential roles of TGF-β in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+ CD4+ regulatory T cells
Hu The immunoregulation of autoimmune diabetes
Cimons The Impact of Lineage-Specifying Transcription Factor Overexpression on Car T Cell Function
Yu Mechanism (s) of Action of the Novel Immunoregulatory Molecule, CD200
Pei Studies of innate regulation of sterile inflammation in cancer and autoimmunity
Moon Engineering homing properties of cancer-specific T lymphocytes in adoption cell therapy
Scamardella Molecular regulation of memory T cell differentiation and function
Yu molecule, CD200
WO2025225648A1 (en) Composition for treating cancer
Verbaro Epigenetic and Signaling Pathways Regulating the Maintenance of CD8 T Cell Identity and Function